Stay updated on GP2013 in RA Refractory/Intolerant Clinical Trial
Sign up to get notified when there's something new on the GP2013 in RA Refractory/Intolerant Clinical Trial page.

Latest updates to the GP2013 in RA Refractory/Intolerant Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRheumatoid arthritis and MedlinePlus Genetics were added under related topics, expanding the disease and related resources. The site revision version was updated from v3.6.2 to v3.6.3.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision: v3.6.2 was added to the page, and the older Revision: v3.6.0 was removed. The related topics section was updated to remove Rheumatoid arthritis and MedlinePlus Genetics.SummaryDifference0.1%

- Check31 days agoChange DetectedThe recruitment status now shows 'No longer looking for participants', indicating the study is not currently enrolling. The page also adds new help/section labels (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label with a new Revision: v3.6.0, replacing the older Interventions label and Revision: v3.5.5.SummaryDifference0.3%

- Check38 days agoChange DetectedThe page footer now shows Revision: v3.5.5, replacing the prior v3.5.4. This indicates a small internal update to the page version without substantive changes to the study information.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a platform/template update. No changes were made to study content or visible functionality on the page.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page’s displayed system/release revision label has been updated from v3.5.2 to v3.5.3, indicating a minor platform/version change without altering the study content.SummaryDifference0.0%

Stay in the know with updates to GP2013 in RA Refractory/Intolerant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GP2013 in RA Refractory/Intolerant Clinical Trial page.